Details of the Drug-Related molecule(s) Interaction Atlas

General Information of Drug (ID: DMRXCYF)

Drug Name
US9586942, 3* Drug Info
Synonyms SCHEMBL16651324; BDBM294229; US9586942, 3*
Cross-matching ID
PubChem CID
118022168
TTD Drug ID
DMRXCYF

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Patented Agent(s)
Download the Complete Related Drug List
Drug(s) Targeting N-acetylglucosaminyltransferase I (NAGAT1)
Drug Name Drug ID Indication ICD 11 Highest Status REF
US9656955, Example 652 DMKS7D9 N. A. N. A. Patented [2]
US9586945, 1 DM2RE91 N. A. N. A. Patented [3]
US9586945, 19a DMKZC4V N. A. N. A. Patented [3]
US9586942, 2 DMZ745J N. A. N. A. Patented [1]
US9656955, Example 540 DMC3Q9O N. A. N. A. Patented [2]
US9586942, 16 DMERWUQ N. A. N. A. Patented [1]
US9656955, Example 351 DMXU8DI N. A. N. A. Patented [2]
US9586945, 5 DM6A8XJ N. A. N. A. Patented [3]
⏷ Show the Full List of 8 Drug(s)

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas
Download the Complete Interaction Atlas for Visualization in Cytoscape

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
N-acetylglucosaminyltransferase I (NAGAT1) TTYJRN5 MGAT1_HUMAN Inhibitor [1]

References

1 Aminotetraline and aminoindane derivatives, pharmaceutical compositions containing them, and their use in therapy. US9586942.
2 Pyrrolidine derivatives, pharmaceutical compositions containing them, and their use in therapy. US9656955.
3 Aminochromane, aminothiochromane and amino-1,2,3,4-tetrahydroquinoline derivatives, pharmaceutical compositions containing them, and their use in therapy. US9586945.